SlideShare ist ein Scribd-Unternehmen logo
1 von 12
Acute Respiratory Distress Syndrome




ARDS
Overview
 • Previously called Adult Respiratory Distress Syndrome
 • Defined in 1994 American-European Consensus
   Conference on ARDS:
   •   Most sever Acute Lung Injury
   •   Diffuse alveolar damage
   •   Severe hypoxemia (PaO2/FIO2 < 200)
   •   Bilateral pulmonary infiltrates
   •   Absence of cardiogenic pulmonary edema (PCWP <18
       mmHg)
Epidemiology
  • 75 cases/ 100,000 population
  • Can occur at any age
  • Risks
    • advanced age
    • No sex preference
      • female sex (only in trauma)
    • cigarette smoking
    • alcohol use.
  • High APACHE score (any underlying cause)
Pathophysiology
 • Diffuse alveolar damage
   •   Increased permeability
   •   Damage to alveolar or capillary endothelium
   •   Inflammation (cytokines, leukotrienes, TNF)
   •   Increased neutrophils ? Reactive
 • Severe pulmonary shunting  hypoxemia
 • Pulmonary hypertension
Causative Insults

   • Sepsis        • Aspiration
   • Trauma        • Drug overdose
   • Fractures     • Near drowning
   • Burns         • Cardiopulmonary
   • Massive         bypass
     transfusion   • Pancreatitis
   • Pneumonia     • Fat embolism
Presentation
 • Acute dyspnea and hypoxemia
    • within hours to days of an inciting event
 • Critically ill
    •   Dyspnea, rapidly progressing
    •   Tachypnea
    •   Agitation
    •   Increasing O2 demands
    •   Often multisystem organ failure
Physical Exam
 • Unspecific
   •   Tachypnea
   •   Tachycardia
   •   Cyanosis
   •   Rales
 • Sepsis
   • Hypotension
   • Peripheral vasoconstriction
 • Manifestation of the underlying cause
   • i.e abdominal finding pancreatitis
Differential Diagnosis
  • Pulmonary hemorrhage     • Transfusion-related
  • Near drowning              acute lung injury (TRALI)
  • Drug reaction            • Acute eosinophilic
  • Noncardiogenic             pneumonia
    pulmonary edema          • Reperfusion injury
  • Hamman-Rich              • Leukemic infiltration
    syndrome                 • Fat embolism syndrome
  • Retinoic acid syndrome   • Acute hypersensitivity
                               pneumonitis
Workup
 • ABG
   • Hypoxemia
   • Respiratory alkalosis initially
   • Respiratory Acidosis ( late)
 • BNP- exclude cardiogenic pulmonary edema
 • CXR diffuse bilateral infiltrates
 • Echocardiogram
 • Possible CT
Treatment
 • Treatment is supportive + underlying cause
 • No effective drug for prevention nor management
   • Xigris
   • Nitric Oxide
   • Liquid surfactant
 • New hopes
   • Simvastatin
   • TNF and interleukin antibodies
Treatment
 • Fluid management
   • Resuscitation vs. maintenance
   • Negative fluid balance “dry side of normal”
 • Ventilation
   • Lung protective
     • High PEEP ( , low TV ( 6 mL/kg)
     • Neuromuscular block- improved 90 day survival
     • ECMO- no improved survival
     • Proning- no improve survival
 • Nutrition
   • Enteral, antioxidants, eicosapentaenoic acid, and gamma-linoleic acid
Prognosis
 • Mortality
   •   Before 1990 , 40-70%
   •   Recent 30-40%
   •   Better understanding and treatment of sepsis.
   •   Increased in older patients
 • Morbidity
   • VAP
   • Weight loss/muscle weakness
   • Only 49% survivors return to work

Weitere ähnliche Inhalte

Was ist angesagt?

Hemolytic transfusion reaction
Hemolytic transfusion reactionHemolytic transfusion reaction
Hemolytic transfusion reaction
Shreyas Kate
 

Was ist angesagt? (19)

Liver cirrhosis (Causes, clinical manifestation, complications, diagnosis, tr...
Liver cirrhosis (Causes, clinical manifestation, complications, diagnosis, tr...Liver cirrhosis (Causes, clinical manifestation, complications, diagnosis, tr...
Liver cirrhosis (Causes, clinical manifestation, complications, diagnosis, tr...
 
Renal Hypertension
Renal HypertensionRenal Hypertension
Renal Hypertension
 
Hepatopulmonary syndrome by Albin Joseph
Hepatopulmonary syndrome  by Albin JosephHepatopulmonary syndrome  by Albin Joseph
Hepatopulmonary syndrome by Albin Joseph
 
Pharmacology: Antimuscarinic ganglion block Vighnesh D
Pharmacology: Antimuscarinic ganglion block Vighnesh DPharmacology: Antimuscarinic ganglion block Vighnesh D
Pharmacology: Antimuscarinic ganglion block Vighnesh D
 
Embolic and thromboembolic diseases
Embolic and thromboembolic diseasesEmbolic and thromboembolic diseases
Embolic and thromboembolic diseases
 
seminar on Leg swelling & its causes
seminar on Leg swelling & its causesseminar on Leg swelling & its causes
seminar on Leg swelling & its causes
 
DIC disseminated intravascular coagulation
DIC disseminated intravascular coagulationDIC disseminated intravascular coagulation
DIC disseminated intravascular coagulation
 
1 edema
1 edema1 edema
1 edema
 
Shock and its management final/ dental implant courses
Shock and its management final/ dental implant coursesShock and its management final/ dental implant courses
Shock and its management final/ dental implant courses
 
Vasculitis 130522234019-phpapp02
Vasculitis 130522234019-phpapp02Vasculitis 130522234019-phpapp02
Vasculitis 130522234019-phpapp02
 
Hypertension and kidney
Hypertension and kidneyHypertension and kidney
Hypertension and kidney
 
Liver disease
Liver diseaseLiver disease
Liver disease
 
Insuficiencia respiratoria
Insuficiencia respiratoriaInsuficiencia respiratoria
Insuficiencia respiratoria
 
Oedema and hyperemia
Oedema and hyperemiaOedema and hyperemia
Oedema and hyperemia
 
Thromboembolism in pregnancy
Thromboembolism in pregnancyThromboembolism in pregnancy
Thromboembolism in pregnancy
 
Hemolytic transfusion reaction
Hemolytic transfusion reactionHemolytic transfusion reaction
Hemolytic transfusion reaction
 
Hepatopulmonary syndrome
Hepatopulmonary syndromeHepatopulmonary syndrome
Hepatopulmonary syndrome
 
Postoperative complications
Postoperative complicationsPostoperative complications
Postoperative complications
 
Sepsis and septic shock
Sepsis  and septic shockSepsis  and septic shock
Sepsis and septic shock
 

Andere mochten auch

Neuroradiology for pathologists
Neuroradiology for pathologistsNeuroradiology for pathologists
Neuroradiology for pathologists
Nitin Tiple
 
Damage control surgery
Damage control surgeryDamage control surgery
Damage control surgery
Dalitso Phiri
 
Toxic shock syndrome
Toxic shock syndromeToxic shock syndrome
Toxic shock syndrome
Babak Jebelli
 

Andere mochten auch (20)

Takotsubo
TakotsuboTakotsubo
Takotsubo
 
Wound Care SCGH
Wound Care SCGHWound Care SCGH
Wound Care SCGH
 
First seizure emergency investigation
First seizure emergency investigationFirst seizure emergency investigation
First seizure emergency investigation
 
Non invasive cardiac testing for acute coronary syndrome
Non invasive cardiac testing for acute coronary syndromeNon invasive cardiac testing for acute coronary syndrome
Non invasive cardiac testing for acute coronary syndrome
 
Trauma resuscitation
Trauma resuscitationTrauma resuscitation
Trauma resuscitation
 
Neuroradiology for pathologists
Neuroradiology for pathologistsNeuroradiology for pathologists
Neuroradiology for pathologists
 
First seizure study SCGH
First seizure study SCGHFirst seizure study SCGH
First seizure study SCGH
 
Toxicology and the ECG
Toxicology and the ECGToxicology and the ECG
Toxicology and the ECG
 
Damage control resuscitation
Damage control resuscitationDamage control resuscitation
Damage control resuscitation
 
Facial Trauma
Facial TraumaFacial Trauma
Facial Trauma
 
Electrical injuries
Electrical injuriesElectrical injuries
Electrical injuries
 
Damage control surgery
Damage control surgeryDamage control surgery
Damage control surgery
 
Resuscitative Thoracotomy
Resuscitative ThoracotomyResuscitative Thoracotomy
Resuscitative Thoracotomy
 
Paediatric Rashes
Paediatric Rashes Paediatric Rashes
Paediatric Rashes
 
CME intro 2017.1
CME intro 2017.1CME intro 2017.1
CME intro 2017.1
 
Emergency ophthalmology
Emergency ophthalmologyEmergency ophthalmology
Emergency ophthalmology
 
Neuroradiology for the ED
Neuroradiology for the EDNeuroradiology for the ED
Neuroradiology for the ED
 
Damage control resuscitation
Damage control resuscitationDamage control resuscitation
Damage control resuscitation
 
Toxic shock syndrome
Toxic shock syndromeToxic shock syndrome
Toxic shock syndrome
 
Toxidromes
ToxidromesToxidromes
Toxidromes
 

Ähnlich wie Ard spresentation

Respiratory Distress in Newborns
Respiratory Distress in NewbornsRespiratory Distress in Newborns
Respiratory Distress in Newborns
The Medical Post
 
deep vein thrombosis ANTICOAGULANTS.pptx
deep vein thrombosis ANTICOAGULANTS.pptxdeep vein thrombosis ANTICOAGULANTS.pptx
deep vein thrombosis ANTICOAGULANTS.pptx
SonuSonu100831
 
Respiratory Complication Of Rheumatic Disease
Respiratory Complication Of Rheumatic DiseaseRespiratory Complication Of Rheumatic Disease
Respiratory Complication Of Rheumatic Disease
drmomusa
 
Anesthesia for laparacopic surgery 2022.
Anesthesia for laparacopic surgery 2022.Anesthesia for laparacopic surgery 2022.
Anesthesia for laparacopic surgery 2022.
FatosKatanolli1
 

Ähnlich wie Ard spresentation (20)

6) respiratory failure.pptx
6) respiratory failure.pptx6) respiratory failure.pptx
6) respiratory failure.pptx
 
Anesthesia in Restrictive lung disease
Anesthesia in Restrictive lung diseaseAnesthesia in Restrictive lung disease
Anesthesia in Restrictive lung disease
 
Management of massive hemoptysis.pptx
Management of massive hemoptysis.pptxManagement of massive hemoptysis.pptx
Management of massive hemoptysis.pptx
 
Respiratory.ppt Pathology of the respiratory system
Respiratory.ppt Pathology of the respiratory systemRespiratory.ppt Pathology of the respiratory system
Respiratory.ppt Pathology of the respiratory system
 
Respiratory Distress in Newborns
Respiratory Distress in NewbornsRespiratory Distress in Newborns
Respiratory Distress in Newborns
 
Ards rahul
Ards rahulArds rahul
Ards rahul
 
G05 ards, fes, dvt, pe
G05 ards, fes, dvt, peG05 ards, fes, dvt, pe
G05 ards, fes, dvt, pe
 
deep vein thrombosis ANTICOAGULANTS.pptx
deep vein thrombosis ANTICOAGULANTS.pptxdeep vein thrombosis ANTICOAGULANTS.pptx
deep vein thrombosis ANTICOAGULANTS.pptx
 
Pulmonary Hypertension - Dr. Tinku Joseph
Pulmonary Hypertension - Dr. Tinku JosephPulmonary Hypertension - Dr. Tinku Joseph
Pulmonary Hypertension - Dr. Tinku Joseph
 
GENERAL PHYSICAL EXAMINATION OF GIT, RS,.pptx
GENERAL PHYSICAL EXAMINATION OF GIT, RS,.pptxGENERAL PHYSICAL EXAMINATION OF GIT, RS,.pptx
GENERAL PHYSICAL EXAMINATION OF GIT, RS,.pptx
 
Pleural effusion basics
Pleural effusion basicsPleural effusion basics
Pleural effusion basics
 
Emergencies In Oncology
Emergencies In OncologyEmergencies In Oncology
Emergencies In Oncology
 
Respiratory Complication Of Rheumatic Disease
Respiratory Complication Of Rheumatic DiseaseRespiratory Complication Of Rheumatic Disease
Respiratory Complication Of Rheumatic Disease
 
Interstitial Lung Disease
Interstitial Lung DiseaseInterstitial Lung Disease
Interstitial Lung Disease
 
ild-190205120035 (1).pdf
ild-190205120035 (1).pdfild-190205120035 (1).pdf
ild-190205120035 (1).pdf
 
ARDs and lung cancer acute respiratory distress syndrome
ARDs and lung cancer acute respiratory distress syndromeARDs and lung cancer acute respiratory distress syndrome
ARDs and lung cancer acute respiratory distress syndrome
 
Pulmonary Edema
Pulmonary Edema Pulmonary Edema
Pulmonary Edema
 
High altitude illness
High altitude illnessHigh altitude illness
High altitude illness
 
Anesthesia for laparacopic surgery 2022.
Anesthesia for laparacopic surgery 2022.Anesthesia for laparacopic surgery 2022.
Anesthesia for laparacopic surgery 2022.
 
Fat embolism
Fat embolismFat embolism
Fat embolism
 

Ard spresentation

  • 2. Overview • Previously called Adult Respiratory Distress Syndrome • Defined in 1994 American-European Consensus Conference on ARDS: • Most sever Acute Lung Injury • Diffuse alveolar damage • Severe hypoxemia (PaO2/FIO2 < 200) • Bilateral pulmonary infiltrates • Absence of cardiogenic pulmonary edema (PCWP <18 mmHg)
  • 3. Epidemiology • 75 cases/ 100,000 population • Can occur at any age • Risks • advanced age • No sex preference • female sex (only in trauma) • cigarette smoking • alcohol use. • High APACHE score (any underlying cause)
  • 4. Pathophysiology • Diffuse alveolar damage • Increased permeability • Damage to alveolar or capillary endothelium • Inflammation (cytokines, leukotrienes, TNF) • Increased neutrophils ? Reactive • Severe pulmonary shunting  hypoxemia • Pulmonary hypertension
  • 5. Causative Insults • Sepsis • Aspiration • Trauma • Drug overdose • Fractures • Near drowning • Burns • Cardiopulmonary • Massive bypass transfusion • Pancreatitis • Pneumonia • Fat embolism
  • 6. Presentation • Acute dyspnea and hypoxemia • within hours to days of an inciting event • Critically ill • Dyspnea, rapidly progressing • Tachypnea • Agitation • Increasing O2 demands • Often multisystem organ failure
  • 7. Physical Exam • Unspecific • Tachypnea • Tachycardia • Cyanosis • Rales • Sepsis • Hypotension • Peripheral vasoconstriction • Manifestation of the underlying cause • i.e abdominal finding pancreatitis
  • 8. Differential Diagnosis • Pulmonary hemorrhage • Transfusion-related • Near drowning acute lung injury (TRALI) • Drug reaction • Acute eosinophilic • Noncardiogenic pneumonia pulmonary edema • Reperfusion injury • Hamman-Rich • Leukemic infiltration syndrome • Fat embolism syndrome • Retinoic acid syndrome • Acute hypersensitivity pneumonitis
  • 9. Workup • ABG • Hypoxemia • Respiratory alkalosis initially • Respiratory Acidosis ( late) • BNP- exclude cardiogenic pulmonary edema • CXR diffuse bilateral infiltrates • Echocardiogram • Possible CT
  • 10. Treatment • Treatment is supportive + underlying cause • No effective drug for prevention nor management • Xigris • Nitric Oxide • Liquid surfactant • New hopes • Simvastatin • TNF and interleukin antibodies
  • 11. Treatment • Fluid management • Resuscitation vs. maintenance • Negative fluid balance “dry side of normal” • Ventilation • Lung protective • High PEEP ( , low TV ( 6 mL/kg) • Neuromuscular block- improved 90 day survival • ECMO- no improved survival • Proning- no improve survival • Nutrition • Enteral, antioxidants, eicosapentaenoic acid, and gamma-linoleic acid
  • 12. Prognosis • Mortality • Before 1990 , 40-70% • Recent 30-40% • Better understanding and treatment of sepsis. • Increased in older patients • Morbidity • VAP • Weight loss/muscle weakness • Only 49% survivors return to work